306 related articles for article (PubMed ID: 11278243)
1. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
Kashiwagi M; Tortorella M; Nagase H; Brew K
J Biol Chem; 2001 Apr; 276(16):12501-4. PubMed ID: 11278243
[TBL] [Abstract][Full Text] [Related]
2. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
Hashimoto G; Aoki T; Nakamura H; Tanzawa K; Okada Y
FEBS Lett; 2001 Apr; 494(3):192-5. PubMed ID: 11311239
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
8. Aggrecanases and cartilage matrix degradation.
Nagase H; Kashiwagi M
Arthritis Res Ther; 2003; 5(2):94-103. PubMed ID: 12718749
[TBL] [Abstract][Full Text] [Related]
9. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
10. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
11. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes.
Tortorella MD; Arner EC; Hills R; Easton A; Korte-Sarfaty J; Fok K; Wittwer AJ; Liu RQ; Malfait AM
J Biol Chem; 2004 Apr; 279(17):17554-61. PubMed ID: 14715656
[TBL] [Abstract][Full Text] [Related]
12. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
14. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.
Nakamura H; Fujii Y; Inoki I; Sugimoto K; Tanzawa K; Matsuki H; Miura R; Yamaguchi Y; Okada Y
J Biol Chem; 2000 Dec; 275(49):38885-90. PubMed ID: 10986281
[TBL] [Abstract][Full Text] [Related]
15. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
[TBL] [Abstract][Full Text] [Related]
16. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
17. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
Wang WM; Ge G; Lim NH; Nagase H; Greenspan DS
Biochem J; 2006 Sep; 398(3):515-9. PubMed ID: 16771712
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.
Westling J; Fosang AJ; Last K; Thompson VP; Tomkinson KN; Hebert T; McDonagh T; Collins-Racie LA; LaVallie ER; Morris EA; Sandy JD
J Biol Chem; 2002 May; 277(18):16059-66. PubMed ID: 11854269
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
